Life Science Tool Sales

Life Science Tool Sales Market Outlook

The global life science tool sales market is projected to reach USD 120 billion by 2035, with a compound annual growth rate (CAGR) of 7.8% from 2025 to 2035. This considerable growth can be attributed to the increasing investments in biotechnology and pharmaceuticals, driven by the need for innovative solutions in drug discovery and development. Moreover, the rising prevalence of chronic diseases and the growth of personalized medicine are propelling the demand for advanced life science tools. Another growth factor includes the rapid advancements in genomics and proteomics, which are enhancing research capabilities and accelerating the development of novel therapeutic approaches. Furthermore, the ongoing integration of artificial intelligence and machine learning in life science tools is expected to revolutionize the industry, enabling more efficient data analysis and interpretation.

Growth Factor of the Market

The life science tool sales market is experiencing significant growth, fueled by a multitude of factors. One of the primary growth drivers is the increasing demand for efficient and accurate diagnostic tools, which is critical for early disease detection and patient management. Additionally, the expansion of biopharmaceutical companies focusing on personalized medicine is creating a robust demand for advanced life science tools that aid in research and development. The rise of biotechnology innovations, including CRISPR technology and cell and gene therapies, further enhances the market landscape by requiring specialized instruments and consumables. Public and private funding for research initiatives is also on the rise, providing the necessary resources for the development and implementation of life science tools. Lastly, the globalization of research collaborations is promoting the exchange of knowledge and technology, resulting in enhanced productivity and innovation within the life sciences sector.

Key Highlights of the Market

• The life science tool sales market is witnessing a rapid shift towards automation and digital technologies.
• North America dominates the market due to its advanced healthcare infrastructure and significant research funding.
• The consumables segment is anticipated to witness the highest growth, driven by the increasing use of disposable products.
• Research applications hold a substantial share of the market, reflecting the importance of innovation in drug discovery.
• Strategic collaborations between companies are becoming increasingly common to enhance product offerings and market reach.

By Product Type

Instruments:

The instruments segment is a crucial component of the life science tools market, encompassing various sophisticated devices that facilitate laboratory procedures and research activities. Instruments such as spectrophotometers, chromatographs, and mass spectrometers play a significant role in analytical testing and quality control processes within pharmaceutical and biotechnology companies. The demand for these instruments is primarily driven by their ability to provide accurate and reliable results, which are essential for regulatory compliance. Additionally, advancements in technology have led to the development of more compact and user-friendly instruments, making them accessible to a broader range of research facilities. As the trend towards automation in laboratories continues, the instruments segment is expected to see a notable increase in adoption rates, further propelling market growth.

Consumables:

The consumables segment includes a wide array of products such as reagents, kits, and laboratory supplies that are essential for conducting experiments and assays. This segment is anticipated to experience substantial growth, fueled by the increasing volume of research activities and the demand for high-quality materials. Consumables are often required in large quantities, leading to recurring revenue opportunities for manufacturers. The rise of personalized medicine and targeted therapies is also contributing to the demand for specialized consumables that cater to specific research needs. Moreover, the trend towards single-use and disposable products is enhancing the safety and efficiency of laboratory operations, further driving the growth of this segment in the life science tools market.

Services:

The services segment encompasses a wide range of offerings, including maintenance, training, and consultancy services related to life science tools. As laboratories increasingly rely on sophisticated technologies, the need for expert guidance and support is growing. The services segment plays a vital role in ensuring the optimal performance of life science tools, thereby contributing to improved research outcomes. Additionally, the emphasis on regulatory compliance in the pharmaceutical and biotechnology sectors is leading to increased demand for validation and calibration services. With a focus on enhancing customer experience and operational efficiency, service providers are continuously evolving their offerings to meet the diverse needs of their clients, further boosting the growth of this segment.

Software:

The software segment of the life science tools market is rapidly growing, driven by the increasing integration of digital technologies in laboratory settings. Software solutions are essential for data management, analysis, and visualization in life science research, enabling scientists to derive meaningful insights from complex datasets. The rise of big data and analytics in the life sciences field is fueling the demand for advanced software applications that support modeling, simulation, and data mining. Furthermore, the growing importance of compliance with regulatory standards necessitates robust software solutions for documentation and reporting purposes. As more laboratories adopt cloud-based platforms and integrated systems, the software segment is expected to play a pivotal role in transforming research methodologies and enhancing productivity across the industry.

Accessories:

The accessories segment consists of various supplementary products that support the functionality and efficiency of life science tools. This includes items such as pipettes, microplates, filters, and various laboratory consumables that are essential for conducting experiments. The demand for accessories is closely tied to the growth of the other segments, as they are necessary for the effective operation of instruments and consumables. As laboratories strive to enhance their workflows and improve outcomes, the need for high-quality accessories is becoming increasingly important. Moreover, with the growing trend towards automation and robotics in laboratory settings, the accessories segment is expected to see continued growth as facilities invest in additional tools to optimize processes.

By Application

Research:

The research segment is a key driver of the life science tools market, encompassing a broad range of activities aimed at advancing scientific knowledge and discovery. This includes fundamental research in areas such as molecular biology, genetics, and biochemistry, as well as applied research focused on developing new therapeutics and diagnostics. The increasing emphasis on innovation and the growing number of research initiatives funded by both public and private entities are contributing to the expansion of this segment. As researchers seek more sophisticated tools to enhance their experiments and achieve more accurate results, the demand for advanced instruments and consumables is expected to continue rising, driving further growth in the life science tools market.

Diagnostics:

The diagnostics application segment plays a crucial role in the life science tools market, focusing on the development of tools and techniques for disease detection and monitoring. With the increasing prevalence of chronic diseases and the rising demand for early diagnosis, the need for accurate and reliable diagnostic tools is becoming more pronounced. Innovations in molecular diagnostics, point-of-care testing, and companion diagnostics are driving advancements in this segment, requiring sophisticated instruments and consumables. As healthcare systems increasingly adopt personalized and precision medicine approaches, the diagnostics segment is poised for significant growth, reflecting the critical importance of early detection and targeted treatments.

Biopharmaceutical Production:

The biopharmaceutical production segment is essential in the life science tools market, focusing on the development and manufacturing of biologic drugs. This includes the production of monoclonal antibodies, vaccines, and other biologics, all of which require specialized tools and technologies for their development. The growing demand for biologics, coupled with advancements in bioprocessing technologies, is driving the expansion of this segment. Additionally, the trend towards continuous manufacturing and process intensification is leading to the adoption of advanced life science tools that enhance efficiency and reduce production costs. As the biopharmaceutical sector continues to evolve, the demand for innovative solutions in production processes will further stimulate growth within this segment.

Agriculture:

The agriculture application segment of the life science tools market focuses on developing tools and technologies that support agricultural research and practices. With the increasing global population and the need for sustainable food production, agriculture is becoming increasingly reliant on biotechnology for crop improvement and pest management. Life science tools such as genomic analysis platforms and phenotyping technologies are essential for enhancing agricultural productivity and resilience. As the agricultural sector embraces precision farming and biotechnology innovations, the demand for specialized tools and services is expected to rise significantly, driving growth in this segment of the life science tools market.

Forensics:

The forensics application segment plays a vital role in the life science tools market by providing the necessary tools for criminal investigations and legal proceedings. This includes DNA analysis, toxicology testing, and other forensic techniques that require precise and reliable instruments. The increasing focus on public safety and the growing number of forensic cases are contributing to the demand for advanced life science tools in this field. As forensic laboratories strive to enhance their capabilities and improve turnaround times, the adoption of innovative technologies and methodologies is becoming critical. The ongoing advancements in forensic science are expected to fuel growth in this segment, highlighting the importance of life science tools in ensuring justice and accountability.

By End User

Pharmaceutical & Biotechnology Companies:

Pharmaceutical and biotechnology companies constitute a significant portion of the end-user segment in the life science tools market. These organizations are heavily involved in research and development processes that require a wide array of life science tools for drug discovery, development, and production. The increasing investments in biotechnology and the shift towards biologics are driving the demand for advanced instruments and consumables within this sector. Additionally, the growing emphasis on personalized medicine necessitates the use of sophisticated tools for patient stratification and biomarker discovery. As these companies continue to innovate and expand their product offerings, the demand for life science tools is expected to remain strong, contributing to overall market growth.

Research Institutes:

Research institutes are critical end-users of life science tools, as they conduct various experiments and studies aimed at advancing scientific knowledge. These organizations often engage in fundamental research, applied research, and translational research, requiring a diverse range of instruments and consumables. The increasing collaboration between research institutes and industry players is further driving the demand for life science tools, as they work together to advance projects and share knowledge. The growing focus on interdisciplinary research and the need for innovative solutions are expected to enhance the adoption of life science tools among research institutes, propelling growth in this segment.

Contract Research Organizations:

Contract Research Organizations (CROs) have become essential partners for pharmaceutical and biotechnology companies, providing a range of services including clinical trials, drug development, and regulatory consulting. The growing reliance on CROs to accelerate drug development processes is driving the demand for life science tools within this segment. CROs require access to high-quality instruments and consumables to ensure accurate and reliable results, which are critical for regulatory approval and successful product commercialization. As more companies outsource their research and development activities to CROs, the demand for life science tools is expected to grow significantly, highlighting the importance of this segment in the overall market landscape.

Hospitals & Clinics:

Hospitals and clinics represent a vital end-user segment in the life science tools market, utilizing various diagnostic and analytical tools to provide patient care. The increasing demand for accurate and timely diagnostics is driving the adoption of advanced life science tools within healthcare settings. This includes the use of molecular diagnostics, histopathology, and imaging technologies to support clinical decision-making and patient management. The rising prevalence of chronic diseases and the growing emphasis on preventive care are further intensifying the need for sophisticated diagnostic tools in hospitals and clinics. As healthcare systems invest in modernization and improved patient outcomes, the demand for life science tools is expected to continue rising within this segment.

Forensic Laboratories:

Forensic laboratories are critical end-users of life science tools, utilizing analytical techniques to support criminal justice processes. The demand for accurate and reliable forensic analysis is driving the adoption of specialized instruments and consumables within this segment. Forensic laboratories require a range of tools for DNA analysis, toxicology testing, and chemical analysis to ensure the integrity of evidence and support legal proceedings. As public safety concerns increase and the volume of forensic cases rises, the need for advanced life science tools is becoming more pronounced. The ongoing advancements in forensic science and technology are expected to enhance the capabilities of forensic laboratories, further fueling growth in this segment.

By Sales Channel

Direct Sales:

Direct sales represent a significant channel in the life science tools market, allowing manufacturers to establish direct relationships with their customers. This approach facilitates better communication and understanding of customer needs, enabling companies to tailor their offerings accordingly. Direct sales are particularly valuable in the life sciences industry, where complex products often require comprehensive demonstrations and training. As manufacturers seek to enhance customer experience and build long-term partnerships, the direct sales channel is expected to play a vital role in driving growth within the life science tools market. Furthermore, direct sales enable companies to maintain greater control over their distribution processes, ensuring the consistent delivery of high-quality products and services.

Distributor Sales:

Distributor sales are another important channel in the life science tools market, providing access to a broader customer base through established distribution networks. Distributors often have extensive knowledge of local markets and customer preferences, allowing them to effectively promote and sell life science tools to various end-users. This sales channel is particularly beneficial for manufacturers looking to expand their reach without incurring significant overhead costs associated with direct sales. Additionally, distributors can offer value-added services such as technical support, training, and inventory management, enhancing the overall customer experience. As the demand for life science tools continues to rise, the distributor sales channel is poised for significant growth, complementing the direct sales efforts of manufacturers.

By Region

The regional analysis of the life science tools market reveals significant disparities in market size and growth potential across different regions. North America is currently the dominant region, accounting for approximately 40% of the global market share, driven by its robust healthcare infrastructure, significant research funding, and a strong presence of pharmaceutical and biotechnology companies. The region is expected to witness a CAGR of 8.5% over the forecast period, fueled by the increasing focus on innovation and the development of advanced life science tools. Europe follows closely, capturing around 30% of the market share, with countries like Germany, the UK, and France leading the way. The European market is characterized by a growing emphasis on research collaboration and regulatory compliance, contributing to the demand for high-quality life science tools.

In the Asia Pacific region, the life science tools market is experiencing rapid growth, fueled by the increasing investments in biotechnology and pharmaceuticals. This region is projected to register the highest CAGR of 9.2% during the forecast period, driven by factors such as rising healthcare expenditure, a growing number of research institutions, and government initiatives to promote life sciences. Countries like China and India are at the forefront of this growth, as they continue to expand their research capabilities and enhance their healthcare infrastructure. Latin America and the Middle East & Africa represent smaller market shares, but these regions are gradually gaining traction as demand for life science tools increases in response to evolving healthcare needs and rising research activities.

Opportunities

One of the most promising opportunities in the life science tools market lies in the adoption of advanced technologies such as artificial intelligence and machine learning. These technologies have the potential to revolutionize data analysis and interpretation in life sciences, enabling researchers to derive insights from complex datasets more efficiently. As the demand for personalized medicine continues to rise, there is an increasing need for sophisticated life science tools that can facilitate the identification of biomarkers and patient stratification. Manufacturers that invest in integrating AI and machine learning capabilities into their products are likely to gain a competitive edge and capitalize on this growing trend. Furthermore, the expansion of genomics and proteomics research, fueled by decreasing sequencing costs and advancements in technology, presents significant growth opportunities for life science tool manufacturers.

Another promising avenue for growth in the life science tools market is the increasing focus on sustainability and environmentally friendly practices. As the global awareness of environmental issues rises, there is a growing demand for life science tools that minimize waste and promote sustainability in laboratories. This includes a shift towards single-use and biodegradable consumables, as well as instruments that reduce energy consumption and environmental impact. Companies that prioritize sustainable practices and develop eco-friendly products are likely to attract a broader customer base and enhance their market positioning. Additionally, government initiatives aimed at promoting sustainable research practices can further bolster this opportunity, paving the way for innovation and growth in the life science tools sector.

Threats

Despite the promising growth prospects in the life science tools market, several threats could impact the industry's trajectory. One of the most significant threats is the increasing regulatory scrutiny that life science products face. Regulatory bodies are imposing stricter guidelines and compliance requirements to ensure product safety and efficacy, which can lead to increased costs for manufacturers. Navigating these complex regulatory landscapes can be challenging, particularly for smaller companies that may lack the resources to effectively manage compliance. Additionally, delays in obtaining regulatory approvals can hinder product launches and limit market opportunities, posing a significant threat to the overall growth of the life science tools market.

Another major challenge facing the life science tools market is the rapid pace of technological advancements. As new technologies emerge, companies must continuously innovate and adapt to stay competitive. Failure to keep up with advancements in life science tools can result in lost market share and decreased relevance in an increasingly crowded marketplace. Furthermore, the rise of alternative technologies and methodologies may pose a threat to traditional life science tools, requiring manufacturers to invest in research and development to remain relevant. The ability to anticipate and respond to changing market dynamics will be critical for companies operating in this segment to navigate potential threats effectively.

Competitor Outlook

• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• PerkinElmer, Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Illumina, Inc.
• F. Hoffmann-La Roche AG
• Qiagen N.V.
• GE Healthcare
• Sartorius AG
• BD (Becton, Dickinson and Company)
• Waters Corporation
• Sigma-Aldrich Corporation

The competitive landscape of the life science tools market is characterized by the presence of several key players, each striving to innovate and capture market share. Major companies such as Thermo Fisher Scientific, Abbott Laboratories, and Danaher Corporation lead the market, leveraging their extensive product portfolios and strong brand recognition. These companies engage in continuous research and development to introduce cutting-edge technologies and enhance their offerings. Furthermore, strategic partnerships and collaborations with research institutions and other industry players are common strategies employed by these companies to expand their reach and enhance their capabilities. The competitive landscape is also witnessing an influx of startups and smaller firms focused on niche markets, contributing to a dynamic and rapidly evolving environment.

Thermo Fisher Scientific Inc. is a frontrunner in the life science tools market, offering a comprehensive range of products and services across various segments. The company focuses on innovation and has made significant investments in research and development to enhance its product offerings. With a strong global presence and a commitment to customer satisfaction, Thermo Fisher continues to maintain its leadership position. Abbott Laboratories is another key player in the market, known for its diagnostic solutions and innovative biotechnology products. The company's emphasis on research and development has enabled it to introduce groundbreaking diagnostics tools that address pressing healthcare needs. As Abbott expands its portfolio, it seeks to enhance its role in the life science tools market.

Danaher Corporation has built a strong reputation in the life science tools market through its diverse range of products and solutions catering to various applications. The company's strategy focuses on acquiring innovative companies and integrating their technologies to enhance its offerings. Danaher's commitment to continuous improvement and operational excellence positions it well to capitalize on emerging opportunities in the market. Additionally, Merck KGaA and Illumina, Inc. are significant contributors to the life science tools market, specializing in genomics and molecular diagnostics. Both companies are at the forefront of technological advancements, driving innovation and expanding their market presence. Their expertise in niche areas positions them favorably to address the evolving needs of researchers and healthcare professionals.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Qiagen N.V.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Sartorius AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 GE Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Illumina, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 PerkinElmer, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Waters Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Abbott Laboratories
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Danaher Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 F. Hoffmann-La Roche AG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Sigma-Aldrich Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Agilent Technologies, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Bio-Rad Laboratories, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Life Science Tool Sales Market, By End User
    • 6.1.1 Pharmaceutical & Biotechnology Companies
    • 6.1.2 Research Institutes
    • 6.1.3 Contract Research Organizations
    • 6.1.4 Hospitals & Clinics
    • 6.1.5 Forensic Laboratories
  • 6.2 Life Science Tool Sales Market, By Application
    • 6.2.1 Research
    • 6.2.2 Diagnostics
    • 6.2.3 Biopharmaceutical Production
    • 6.2.4 Agriculture
    • 6.2.5 Forensics
  • 6.3 Life Science Tool Sales Market, By Product Type
    • 6.3.1 Instruments
    • 6.3.2 Consumables
    • 6.3.3 Services
    • 6.3.4 Software
    • 6.3.5 Accessories
  • 6.4 Life Science Tool Sales Market, By Sales Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Life Science Tool Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Life Science Tool Sales market is categorized based on

By Product Type

• Instruments
• Consumables
• Services
• Software
• Accessories

By Application

• Research
• Diagnostics
• Biopharmaceutical Production
• Agriculture
• Forensics

By End User

• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Contract Research Organizations
• Hospitals & Clinics
• Forensic Laboratories

By Sales Channel

• Direct Sales
• Distributor Sales

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• PerkinElmer, Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Illumina, Inc.
• F. Hoffmann-La Roche AG
• Qiagen N.V.
• GE Healthcare
• Sartorius AG
• BD (Becton, Dickinson and Company)
• Waters Corporation
• Sigma-Aldrich Corporation